Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Luneau

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 2, 2017
Comparison of <sup>19</sup>F NMR and <sup>14</sup>C Measurements for the Assessment of ADME of BYL719 (Alpelisib) in HumansAlexander David James, Cyrille Marvalin, Alexandre Luneau, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 15, 2018
David Pearson, Maxime Garnier, Alexandre Luneau, et al.
ACS Medicinal Chemistry Letters|June 14, 2023
Novel Concept for Super-Soft Topical Drugs: Deactivation by an Enzyme-Induced Switch into an Inactive ConformationGebhard Thoma, Eric Vangrevelinghe, Alexandre Luneau, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 24, 2015
Micropreparative isolation and NMR structure elucidation of metabolites of the drug candidate 1-isopropyl-4-(4-isopropylphenyl)-6-(prop-2-yn-1-yloxy) quinazolin-2(1H)-one from rat bile and urineJoachim Blanz, Thierry Délémonté, David Pearson, et al.
Science Advances|October 27, 2023
High-throughput synthesis provides data for predicting molecular properties and reaction successJulian Götz, Moritz K Jackl, Chalupat Jindakun, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 28, 2016
KAE609 (Cipargamin), a New Spiroindolone Agent for the Treatment of Malaria: Evaluation of the Absorption, Distribution, Metabolism, and Excretion of a Single Oral 300-mg Dose of [14C]KAE609 in Healthy Male SubjectsSu-Er W Huskey, Chun-qi Zhu, Andreas Fredenhagen, et al.
SLAS Technology|August 26, 2022
Integrated and automated high-throughput purification of libraries on microscaleCarol Ginsburg-Moraff, Jonathan Grob, Karl Chin, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 28, 2016
Identification of Three Novel Ring Expansion Metabolites of KAE609, a New Spiroindolone Agent for the Treatment of Malaria, in Rats, Dogs, and HumansSu-Er W Huskey, Chun-qi Zhu, Melissa M Lin, et al.
Bioorganic & Medicinal Chemistry|September 19, 2017
Development of a cyclosporin A derivative with excellent anti-hepatitis C virus potencyJiping Fu, Christopher Becker, Li Cao, et al.
Journal of Medicinal Chemistry|July 16, 2020
Discovery and Characterization of Clinical Candidate LXE408 as a Kinetoplastid-Selective Proteasome Inhibitor for the Treatment of LeishmaniasesAdvait Nagle, Agnes Biggart, Celine Be, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 2, 2017
Comparison of <sup>19</sup>F NMR and <sup>14</sup>C Measurements for the Assessment of ADME of BYL719 (Alpelisib) in HumansAlexander David James, Cyrille Marvalin, Alexandre Luneau, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 15, 2018
David Pearson, Maxime Garnier, Alexandre Luneau, et al.
ACS Medicinal Chemistry Letters|June 14, 2023
Novel Concept for Super-Soft Topical Drugs: Deactivation by an Enzyme-Induced Switch into an Inactive ConformationGebhard Thoma, Eric Vangrevelinghe, Alexandre Luneau, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 24, 2015
Micropreparative isolation and NMR structure elucidation of metabolites of the drug candidate 1-isopropyl-4-(4-isopropylphenyl)-6-(prop-2-yn-1-yloxy) quinazolin-2(1H)-one from rat bile and urineJoachim Blanz, Thierry Délémonté, David Pearson, et al.
Science Advances|October 27, 2023
High-throughput synthesis provides data for predicting molecular properties and reaction successJulian Götz, Moritz K Jackl, Chalupat Jindakun, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 28, 2016
KAE609 (Cipargamin), a New Spiroindolone Agent for the Treatment of Malaria: Evaluation of the Absorption, Distribution, Metabolism, and Excretion of a Single Oral 300-mg Dose of [14C]KAE609 in Healthy Male SubjectsSu-Er W Huskey, Chun-qi Zhu, Andreas Fredenhagen, et al.
SLAS Technology|August 26, 2022
Integrated and automated high-throughput purification of libraries on microscaleCarol Ginsburg-Moraff, Jonathan Grob, Karl Chin, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 28, 2016
Identification of Three Novel Ring Expansion Metabolites of KAE609, a New Spiroindolone Agent for the Treatment of Malaria, in Rats, Dogs, and HumansSu-Er W Huskey, Chun-qi Zhu, Melissa M Lin, et al.
Bioorganic & Medicinal Chemistry|September 19, 2017
Development of a cyclosporin A derivative with excellent anti-hepatitis C virus potencyJiping Fu, Christopher Becker, Li Cao, et al.
Journal of Medicinal Chemistry|July 16, 2020
Discovery and Characterization of Clinical Candidate LXE408 as a Kinetoplastid-Selective Proteasome Inhibitor for the Treatment of LeishmaniasesAdvait Nagle, Agnes Biggart, Celine Be, et al.
Pageof 1